Ingersoll Rand has shown promising growth but underperformed in the market occasionally. However, the firm has made strategic acquisitions like
Oxywise and
Fraserwoods, while leading a $19M financing round for
Inkbit. Notably, the quarterly earnings have often topped estimates despite revenue shortfalls. The company also acquired
ILC, signifying expansion in the life sciences unit. They have recorded successful stock sales and even released impressive FY24 earning guidance. Slight downward trends in the stock price were recorded, but the company stands firm with a solid balance sheet. Despite occasional share sales by banks and advisors, new shares are routinely acquired. Several brokerages support a confident price target while retirement funds adjust their stock holdings. The firm's decision to offer regular
quarterly cash dividends and increased share repurchase authorization supports its strong growth profile.
Ingersoll Rand IR News Analytics from Mon, 21 Aug 2023 07:00:00 GMT to Thu, 09 May 2024 20:59:00 GMT -
Rating 4
- Innovation 5
- Information 8
- Rumor -1
